Showing results (91-100 of 185) with videos related to

Sort By:
Pageof 19
Revista De Psiquiatria Y Salud Mental|December 5, 2012
Assessing clinical and functional outcomes in a gene-environment interaction study in first episode of psychosis (PEPs)Miquel Bernardo, Miquel Bioque, Mara Parellada, et al.
Schizophrenia Research|December 25, 2017
BDNF as a marker of response to cognitive remediation in patients with schizophrenia: A randomized and controlled trialRafael Penadés, Irene López-Vílchez, Rosa Catalán, et al.
BMC Psychiatry|September 10, 2017
Protocol for the management of psychiatric patients with psychomotor agitationEduard Vieta, Marina Garriga, Laura Cardete, et al.
Psychopharmacology|June 15, 2019
Food craving and consumption evolution in patients starting treatment with clozapineMarina Garriga, Andrea Mallorquí, Lourdes Serrano, et al.
Journal of Clinical Psychopharmacology|March 2, 2005
Volume changes in gray matter in first-episode neuroleptic-naive schizophrenic patients treated with risperidoneGuillem Massana, Pilar Salgado-Pineda, Carme Junqué, et al.
Comprehensive Psychiatry|December 9, 2008
Adaptation and validation of the quality-of-life scale: Satisfaction with Life Domains Scale by Baker and IntagliataJanina Carlson, Susana Ochoa, Josep Maria Haro, et al.
Spanish Journal of Psychiatry and Mental Health|January 13, 2024
Impact of cognitive reserve in clinical, neurocognitive and lifestyle factors in chronic schizophrenia and early stages of schizophreniaSilvia Amoretti, Gerard Anmella, Miquel Bernardo, et al.
Neurology and Therapy|January 6, 2025
Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert PanelMiquel Bernardo, Marina Díaz Marsá, Ana González-Pinto, et al.
Pageof 19